Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Shareholder Equity 2016–2025
Moleculin Biotech Inc. annual/quarterly shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Moleculin Biotech Inc. shareholder equity for the quarter ending December 31, 2025 were 15.0M, a 33.89% increase year-over-year.
- Moleculin Biotech Inc. shareholder equity for 2025 were 15.0M, a 33.89% increase from 2024.
- Moleculin Biotech Inc. shareholder equity for 2024 were 11.2M, a 63.76% decrease from 2023.
- Moleculin Biotech Inc. shareholder equity for 2023 were 30.9M, a 40.74% decrease from 2022.
- Moleculin Biotech Inc. shareholder equity for 2022 were 52.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Moleculin Biotech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $15 |
| 2024 | $11 |
| 2023 | $31 |
| 2022 | $52 |
| 2021 | $79 |
| 2020 | $18 |
| 2019 | $16 |
| 2018 | $14 |
| 2017 | $17 |
| 2016 | $15 |
| Moleculin Biotech Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $15 |
| 2024-12-31 | $11 |
| 2023-12-31 | $31 |
| 2022-12-31 | $52 |
| 2021-12-31 | $79 |
| 2020-12-31 | $18 |
| 2019-12-31 | $16 |
| 2018-12-31 | $14 |
| 2017-12-31 | $17 |
| 2016-12-31 | $15 |
Moleculin Biotech Inc. Shareholder Equity — FAQ
Moleculin Biotech Inc. (MBRX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MBRX's shareholder equity history?
The chart and table above show Moleculin Biotech Inc.'s shareholder equity by year and by quarter, including the growth rate.